Status:
COMPLETED
Cardiac Dysfunction in Critically Ill Covid-19 Patients
Lead Sponsor:
Region Stockholm
Collaborating Sponsors:
Karolinska Institutet
Conditions:
COVID-19
ARDS, Human
Eligibility:
All Genders
18+ years
Brief Summary
We conducted an observation sub-study of the prospective randomized controlled trial "High Dose Inhaled Nitric Oxide in Acute Hypoxemic Respiratory Failure", in which we analysed the echocardiographic...
Detailed Description
We conducted an observation sub-study of the prospective randomized controlled trial "High Dose Inhaled Nitric Oxide in Acute Hypoxemic Respiratory Failure" which was conducted in 2020/2021 during the...
Eligibility Criteria
Inclusion
- Age ≥18.
- Positive PCR for COVID-19.
- Admission to the ICU.
- Endotracheal intubation and mechanical ventilation.
- Severe hypoxemia, defined by PaO2/FiO2 \< 300 mmHg.
- Inclusion in the trial "High Dose Inhaled Nitric Oxide in Acute Hypoxemic Respiratory Failure"
Exclusion
- Endotracheal intubation for \>72h before inclusion.
- Do not resuscitate order or other limitation of care.
- Known pregnancy.
- Cases where the treating physician opposes inclusion due to safety concerns or considerations that renders inclusion unfeasible.
- Not having had echocardiography performed during the trial period (exclusion criteria for this sub-study).
Key Trial Info
Start Date :
May 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 11 2021
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT06197256
Start Date
May 7 2020
End Date
February 11 2021
Last Update
January 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Danderyds Hospital
Stockholm, Sweden, 182 57